ORALLY DELIVERED METHADONE AS A REINFORCER: EFFECTS OF THE OPIOID ANTAGONIST NALOXONE

Gespeichert in:

Bibliographische Detailangaben
1. Verfasser:	WANG, N.S
Weitere Verfasser:	ET AL
Format:	Journal Article
Sprache:	Englisch
Schlagworte:	Drogodependencias Efectos Experimentación Fármacos Metadona Opiáceos Tratamiento médico Adicciones Documental
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!

Ähnliche Einträge: ORALLY DELIVERED METHADONE AS A REINFORCER: EFFECTS OF THE OPIOID ANTAGONIST NALOXONE

Vorschau
The impact of the opioid antagonist naloxone on experimentally induced craving in nicotine-dependent individuals
Vorschau
EFFECTS OF BUPRENORPHINE AND NALOXONE IN MORPHINE-STABILIZED OPIOID ADDICTS
Vorschau
THE ACCEPTABILITY OF COMBINED METHADONE-NALOXONE TREATMENT: CONSUMER AND PROVIDER VIEWS ON THE POTENTIAL UTILITY OF METHADONE-NALOXONE
Vorschau
Opioid overdose prevention with intranasal naloxone among people who take methadone
Vorschau
UTILITY OF CROSSOVER DESIGNS IN CLINICAL TRIALS: EFFICACY OF DESIPRAMINE VS. PLACEBO IN OPIOID-DEPENDENT COCAINE ABUSERS
Vorschau
OPIOID DETOXIFICATION USING NALOXONE
Vorschau
SUBSTITUTION PHARMACOTHERAPIES FOR OPIOID ADDICTION: FROM METHADONE TO LAAM AND BUPRENORPHINE
Vorschau
TRAINING HEALTH PROFESSIONALS TO DELIVER METHADONE TREATMENT. EN: METHADONE MAINTENANCE TREATMENT AND OTHER OPIOID REPLACEMENT THERAPIES
Vorschau
EVALUATION OF THE EFFECTS OF LOFEXIDINE AND CLONIDINE ON NALOXONE-PRECIPITATED WILTHDRAWAL IN OPIOID-DEPENDENT HUMANS
Vorschau
OPIOID ADDICTS AT ADMISSION VS. SLOW-RELEASE ORAL MORPHINE, METHADONE, AND SUBLINGUAL BUPRENORPHINE MAINTENANCE TREATMENT PARTICIPANTS
Vorschau
TIME COURSE OF NALOXONE-PRECIPITATED WITHDRAWAL AFTER ACUTE METHADONE EXPOSURE IN HUMANS
Vorschau
THREE ORAL FORMULATIONS OF METHADONE. A CLINICAL AND PHARMACODYNAMIC COMPARISON
Vorschau
SUBOXONE (BUPRENORPHINE/NALOXONE) AS AN AGONIST OPIOID TREATMENT IN SPAIN: A BUDGETARY IMPACT ANALYSIS
Vorschau
SUBLINGUAL BUPRENORPHINE/NALOXONE PRECIPITATED WITHDRAWAL IN SUBJECTS MAINTAINED ON 100 MG OF DAILY METHADONE
Vorschau
FLUOXETINE TREATMENT OF DEPRESSIVE DISORDERS IN METHADONE-MAINTAINED OPIOID ADDICTS
Vorschau
Safety and tolerability of slow-release oral morphine versus methadone in the treatment of opioid dependence
Vorschau
TRAMADOL IN OPIATE WITHDRAWAL. EXPLORATORY STUDY. EN: DRUG USE AND THE CRISIS OF EUROPEAN SOCIETIES. REVIEWING THE QUALITY OF INTERVENTIONS. ACTS OF THE 3RD. EUROPEAN CONFERENCE OF PROFESSIONALS WORKING IN THE FIELD OF DRUG ABUSE. BOLOGNA, 5-7 FEBRUARY 1998
Vorschau
THE EFFECTS OF THE OPIOID PHARMACOTHERAPIES METHADONE, LAAM AND BUPRENORPHINE, ALONE AND IN COMBINATION WITH ALCOHOL, ON SIMULATED DRIVING
Vorschau
Buprenorphine-based regimens and methadone for the medical management of opioid dependence: selecting the appropriate drug for treatment
Vorschau
Antagonist Opioid Medications in Mental Illness: State of Art and Future Perspectives
Vorschau
Cost-effectiveness of diacetylmorphine versus methadone for chronic opioid dependence refractory to treatment
Vorschau
KETOCONAZOLE INCREASES COCAINE AND OPIOID USE IN METHADONE MAINTAINED PATIENTS
Vorschau
BUPRENORPHINE-NALOXONE VERSUS METHADONE MAINTENANCE THERAPY: A RANDOMISED DOUBLE-BLIND TRIAL WITH OPIOID-DEPENDENT PATIENTS
Vorschau
OPIOID REINFORCEMENT IN HEROIN-DEPENDENT VOLUNTEERS DURING OUTPATIENT BUPRENORPHINE MAINTENANCE